In this series, we shine a light on some of the extraordinary people we work with. This week, we’re honoured to feature Liz Dawes, the inspiring founder of the Robert Connor Dawes (RCD) Foundation.
Liz has transformed her profound personal loss into a powerful force against paediatric brain cancer, championing groundbreaking research and community support. Here, Liz shares her journey and the significant impacts of her work.
What inspired you to create the RCD Foundation in memory of Connor, and how has it evolved since its inception?
The RCD Foundation is inspired by the big heart and brain of my son, Connor, who lost his battle with brain cancer when he was 18. Twelve years on, we never could have imagined the impact RCD would have on the families and young people impacted by brain cancer. Since our inception, we have raised more than $17 million for research, care, and development.
Can you share a significant milestone or breakthrough that has been particularly rewarding?
In 2024, we launched our brain cancer vaccine project alongside The University of Queensland, which will be the first to apply immunotherapy technology to treat paediatric brain cancer. This approach enhances the body’s natural response against a tumour and will be a world-first.
In what ways has the community contributed to the success of Connor’s Run?
The community is at the heart of the event’s success, bringing together thousands of people who lace up their runners or volunteer along the course each year. This incredible community includes families impacted by paediatric brain cancer, our Bayside community, schools across Melbourne, and the dozens of workplaces that support Connor’s Run annually. Their dedication has shaped the event into what it is today—the largest event for paediatric brain cancer in the country.
Looking ahead, what are the main objectives of the RCD Foundation, and how do you plan to achieve them?
Improving access to clinical trials and technology to enhance treatment outcomes remains a priority, driven by our strong industry partnerships and collaboration. In addition, we are deeply committed to further connecting with the paediatric brain cancer community—providing information, support, and access to our Australia-wide in-home music therapy program. Brain cancer is the most fatal childhood cancer, and we are on a mission to change the odds.
How important are collaborations with organisations like Arize in achieving the foundation’s goals?
Collaborations with organisations like Arize help us share Connor’s story and the lasting impact his life has had with a wide audience, which allows us to ensure no family must endure the same experience as ours did.
To learn more about the RCD Foundation and how you can support their mission to change the odds for children with brain cancer, follow the link.